Neurological perspectives on voltage-gated sodium channels
The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain. Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as m...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437034/ |
id |
pubmed-3437034 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-34370342012-09-10 Neurological perspectives on voltage-gated sodium channels Eijkelkamp, Niels Linley, John E. Baker, Mark D. Minett, Michael S. Cregg, Roman Werdehausen, Robert Rugiero, François Wood, John N. Review Article The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain. Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders. Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels. This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects. We also discuss recent advances in the development of selective sodium channel inhibitors. Oxford University Press 2012-09 2012-08-29 /pmc/articles/PMC3437034/ /pubmed/22961543 http://dx.doi.org/10.1093/brain/aws225 Text en © The Author 2012. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Eijkelkamp, Niels Linley, John E. Baker, Mark D. Minett, Michael S. Cregg, Roman Werdehausen, Robert Rugiero, François Wood, John N. |
spellingShingle |
Eijkelkamp, Niels Linley, John E. Baker, Mark D. Minett, Michael S. Cregg, Roman Werdehausen, Robert Rugiero, François Wood, John N. Neurological perspectives on voltage-gated sodium channels |
author_facet |
Eijkelkamp, Niels Linley, John E. Baker, Mark D. Minett, Michael S. Cregg, Roman Werdehausen, Robert Rugiero, François Wood, John N. |
author_sort |
Eijkelkamp, Niels |
title |
Neurological perspectives on voltage-gated sodium channels |
title_short |
Neurological perspectives on voltage-gated sodium channels |
title_full |
Neurological perspectives on voltage-gated sodium channels |
title_fullStr |
Neurological perspectives on voltage-gated sodium channels |
title_full_unstemmed |
Neurological perspectives on voltage-gated sodium channels |
title_sort |
neurological perspectives on voltage-gated sodium channels |
description |
The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain. Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders. Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels. This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects. We also discuss recent advances in the development of selective sodium channel inhibitors. |
publisher |
Oxford University Press |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437034/ |
_version_ |
1611555145338847232 |